Fluoxetine 90 MG Delayed Release Oral Capsule — RxCUI 313995
RxNorm drug concept · Semantic clinical drug
RxCUI 313995
Semantic clinical drug · SCD
● Current RxNorm concept 1 FDA product
1 package NDC
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI313995
Official nameFluoxetine 90 MG Delayed Release Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asfluoxetine 90 MG (fluoxetine hydrochloride 101 MG) Delayed Release Oral Capsule
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)5,709 prescriptions · 34 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Fluoxetine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Fluoxetine is an SSRI antidepressant. Most products treat major depressive disorder, OCD, bulimia nervosa and panic disorder. Some products, like the delayed-release capsules, are...
- Take it by mouth, usually once a day in the morning, with or without food. Follow the directions on your label. Don't stop suddenly without talking to your prescriber.
- Common ones are nausea, headache, trouble sleeping, nervousness, diarrhea, dry mouth, sleepiness and sweating. Sexual side effects can also happen. Call your doctor if they bother...
- Call for new or worse depression, suicidal thoughts, agitation or unusual behavior changes, especially early on or after dose changes. Also get help for a rash, unusual bleeding, f...
🕸️ Concept Web — How Fluoxetine 90 MG Delayed Release Oral Capsule Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Fluoxetine 90 MG Delayed Release Oral Capsule
RxCUI 313995 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Fluoxetine
4493IN
-
Fluoxetine
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Fluoxetine Delayed Release Oral Capsule
378618SCDF -
Fluoxetine Oral Product
1160836SCDG -
Fluoxetine Pill
1160837SCDG -
Delayed Release Oral Capsule
316995DF -
Oral Product
1151131DFG -
Pill
1151133DFG
-
Fluoxetine Delayed Release Oral Capsule
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Fluoxetine 90 MG
331559SCDC
-
Fluoxetine 90 MG
Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Fluoxetine 90 MG
SCDC · 331559 -
Fluoxetine Delayed Release Oral Capsule
SCDF · 378618 -
Fluoxetine Oral Product
SCDG · 1160836 -
Fluoxetine Pill
SCDG · 1160837
📦 FDA Products & Package NDCs
1 product · 1 package NDC
1 package NDC map to RxCUI 313995 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 55111-0284-48 | 1 BLISTER PACK in 1 CARTON (55111-284-48) / 4 CAPSULE, DELA... | Fluoxetine hydrochloride | Dr.Reddy's Laboratories Limited | 2010-03-24 |
Observed labelers:
Dr.Reddy's Laboratories Limited (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
💲 Pricing (NADAC)
NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$30.5791
Range $30.5791–$30.5791
· middle 50% $30.5791–$30.5791
· 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.